Jackie Wright Bonilla participated in a panel discussing gene patenting issues at the AIPLA Mid-Winter Institute in Orlando February 2-5, 2011.
Related Insights
20 January 2025
PharmaPatents
Federal Circuit Says Proper Orange Book-Listed Patent Must Claim Active Ingredient
In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon of scrutinizing the types of patents that can be listed in the Food & Drug Administration (FDA) Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations), and decided that the “device” patents at issue were not properly listable.
17 January 2025
Foley Career Perspectives
Strive Without Strife: Your Guide to 2025
The start of a new year often inspires lofty resolutions, if not illusions of grandeur, about the habits we’ll develop and professional goals we’ll conquer: more billable hours, bigger matters, rapid career advancement, and the like.
17 January 2025
Consumer Class Defense Counsel
FTC Announces Final Junk Fees Rule Applying to Live-Event Tickets and Short-Term Lodging
On December 17, 2024, the U.S. Federal Trade Commission announced its final “Junk Fees Rule” to prevent certain practices related to pricing in the live-event ticketing and short-term lodging industries.